Decitabine
Disease Related To Hematopoietic Stem Cell Transplant
Chinese PLA General HospitalSmall moleculePhase 4 / ApprovedActive
BBB
72/ 100
Provisional rating · Methodology v0.2
Rating breakdown
- Clinical Evidence
- 61/ 100
- Competitive Position
- 89/ 100
Competitive context
54 Active assets in the Disease Related To Hematopoietic Stem Cell Transplant cohort.
| Asset / Sponsor | Phase | Rating |
|---|---|---|
BUSULFANUM Institute of Hematology & Blood Diseases Hospital, China | Phase 3 | BBB |
Cyclophosphamide The First Affiliated Hospital of Soochow University | Phase 3 | BBB |
Nivestim National Cancer Institute (NCI) | Phase 2/3 | BBB |
Rituximab M.D. Anderson Cancer Center | Phase 2 | BBB |
Cyclosporin A The First Affiliated Hospital of Soochow University | Phase 4 | BB |
View all 50 →
Same molecule, other indications
Decitabine is also rated in:
acute myeloid leukemia with t(8;21)(q22;q22) translocationActive
BB
Indicative · Phase 3
70 / 100
View asset →acute myeloid leukemia with abnormal bone marrow eosinophils inv(16)(p13q22) or t(16;16)(p13;q22)Dormant
BB
Indicative · Phase 3
69 / 100
View asset →Are you the sponsor?
Submit your data room for a Verified Rating. The public-data rating remains visible alongside.
Contact →